Log in
Enquire now
‌

US Patent 8987251 Triazolopyridine compounds as PIM kinase inhibitors

Patent 8987251 was granted and assigned to Array Biopharma Inc. on March, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Array Biopharma Inc.
Array Biopharma Inc.
0
Current Assignee
Array Biopharma Inc.
Array Biopharma Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
89872510
Patent Inventor Names
T. Gregg Davis0
Shelley Allen0
Stefan D. Gross0
Stephen T. Schlachter0
A. Dale Wright0
Bryson Rast0
Erik James Hicken0
Fredrik P. Marmsater0
...
Date of Patent
March 24, 2015
0
Patent Application Number
140578820
Date Filed
October 18, 2013
0
Patent Primary Examiner
‌
Niloofar Rahmani
0
Patent abstract

Provided herein is a method of treating a PIM-1 and/or PIM-2 and/or PIM-3 kinase-mediated condition in a mammal, which comprises administering to said mammal a therapeutically effective amount of a compound of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8987251 Triazolopyridine compounds as PIM kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.